ZA200809820B - A novel crystalline form of lamivudine - Google Patents
A novel crystalline form of lamivudineInfo
- Publication number
- ZA200809820B ZA200809820B ZA2008/09820A ZA200809820A ZA200809820B ZA 200809820 B ZA200809820 B ZA 200809820B ZA 2008/09820 A ZA2008/09820 A ZA 2008/09820A ZA 200809820 A ZA200809820 A ZA 200809820A ZA 200809820 B ZA200809820 B ZA 200809820B
- Authority
- ZA
- South Africa
- Prior art keywords
- lamivudine
- new
- disclosed
- pharmaceutical composition
- same
- Prior art date
Links
- JTEGQNOMFQHVDC-NKWVEPMBSA-N lamivudine Chemical compound O=C1N=C(N)C=CN1[C@H]1O[C@@H](CO)SC1 JTEGQNOMFQHVDC-NKWVEPMBSA-N 0.000 title abstract 3
- 229960001627 lamivudine Drugs 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 239000013078 crystal Substances 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN347KO2006 | 2006-04-18 | ||
| PCT/IN2007/000047 WO2007119248A1 (en) | 2006-04-18 | 2007-02-09 | A novel crystalline form of lamivudine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200809820B true ZA200809820B (en) | 2010-02-24 |
Family
ID=37969898
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2008/09820A ZA200809820B (en) | 2006-04-18 | 2008-11-18 | A novel crystalline form of lamivudine |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8158607B2 (https=) |
| EP (1) | EP2007758B1 (https=) |
| JP (1) | JP5184511B2 (https=) |
| AT (1) | ATE485292T1 (https=) |
| AU (1) | AU2007237818B2 (https=) |
| CA (1) | CA2649796A1 (https=) |
| DE (1) | DE602007009957D1 (https=) |
| ES (1) | ES2357159T3 (https=) |
| WO (1) | WO2007119248A1 (https=) |
| ZA (1) | ZA200809820B (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009037538A2 (en) * | 2007-09-17 | 2009-03-26 | Aurobindo Pharma Ltd | Process for the preparation of lamivudine form i |
| WO2009069014A1 (en) * | 2007-11-29 | 2009-06-04 | Ranbaxy Laboratories Limited | Amorphous lamivudine and its preparation |
| AU2008331168A1 (en) * | 2007-11-29 | 2009-06-04 | Ranbaxy Laboratories Limited | Crystalline form I of lamivudine and its preparation |
| WO2009116055A1 (en) * | 2008-03-17 | 2009-09-24 | Lupin Limited | Lamivudine : zidovudine : water 1 : 1 : 1 cocrystal |
| WO2009127996A1 (en) * | 2008-04-17 | 2009-10-22 | Ranbaxy Laboratories Limited | Novel crystalline form of lamivudine |
| US8536151B2 (en) | 2008-09-01 | 2013-09-17 | Hetero Research Foundation | Process for preparing lamivudine polymorph form |
| US8481554B2 (en) | 2009-05-27 | 2013-07-09 | Hetero Research Foundation | Solid oral dosage forms of lamivudine |
| ES2540074T3 (es) | 2009-10-14 | 2015-07-08 | Mylan Laboratories Limited | Proceso para la preparación de lamivudina y nuevas sales en la fabricación de la misma |
| EP2536715A1 (en) | 2010-02-12 | 2012-12-26 | Merck Sharp & Dohme Corp. | Preparation of lamivudine form i |
| WO2013168066A1 (en) | 2012-05-05 | 2013-11-14 | Lupin Limited | An improved process for the manufacture of lamivudine form i. |
| EP2953945A2 (en) * | 2013-02-07 | 2015-12-16 | Tobira Therapeutics, Inc. | Lamivudine salts |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5047407A (en) * | 1989-02-08 | 1991-09-10 | Iaf Biochem International, Inc. | 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties |
| US5204466A (en) * | 1990-02-01 | 1993-04-20 | Emory University | Method and compositions for the synthesis of bch-189 and related compounds |
| GB9009861D0 (en) | 1990-05-02 | 1990-06-27 | Glaxo Group Ltd | Chemical compounds |
| GB9111902D0 (en) * | 1991-06-03 | 1991-07-24 | Glaxo Group Ltd | Chemical compounds |
| WO2003027106A1 (en) * | 2001-09-25 | 2003-04-03 | Cadila Healthcar Limited | Process for the preparation of crystalline polymorph ii of lamivudine |
-
2007
- 2007-02-09 EP EP07706193A patent/EP2007758B1/en not_active Not-in-force
- 2007-02-09 CA CA002649796A patent/CA2649796A1/en not_active Abandoned
- 2007-02-09 AT AT07706193T patent/ATE485292T1/de not_active IP Right Cessation
- 2007-02-09 ES ES07706193T patent/ES2357159T3/es active Active
- 2007-02-09 DE DE602007009957T patent/DE602007009957D1/de active Active
- 2007-02-09 WO PCT/IN2007/000047 patent/WO2007119248A1/en not_active Ceased
- 2007-02-09 JP JP2009506041A patent/JP5184511B2/ja not_active Expired - Fee Related
- 2007-02-09 AU AU2007237818A patent/AU2007237818B2/en not_active Ceased
- 2007-02-09 US US12/297,174 patent/US8158607B2/en not_active Expired - Fee Related
-
2008
- 2008-11-18 ZA ZA2008/09820A patent/ZA200809820B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE602007009957D1 (de) | 2010-12-02 |
| JP2009534373A (ja) | 2009-09-24 |
| CA2649796A1 (en) | 2007-10-25 |
| WO2007119248A1 (en) | 2007-10-25 |
| ES2357159T3 (es) | 2011-04-19 |
| EP2007758B1 (en) | 2010-10-20 |
| AU2007237818B2 (en) | 2012-09-27 |
| JP5184511B2 (ja) | 2013-04-17 |
| ATE485292T1 (de) | 2010-11-15 |
| EP2007758A1 (en) | 2008-12-31 |
| US20090281053A1 (en) | 2009-11-12 |
| US8158607B2 (en) | 2012-04-17 |
| AU2007237818A1 (en) | 2007-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200809820B (en) | A novel crystalline form of lamivudine | |
| MY181645A (en) | Antibacterial quinoline derivatives | |
| MY167135A (en) | Fused heterocyclic derivatives and methods of use | |
| WO2011048604A3 (en) | Processes for the preparation of darunavir and the amorphous form thereof | |
| UA86614C2 (ru) | Соединение, которое имеет активность ингибитора киназ, фармацевтическая композиция, которая включает указанное соединение, и их применение для приготовления лекарственного препарата | |
| MX2009006764A (es) | Pirimidinonas biciclicas y usos de la misma. | |
| NZ593712A (en) | Intermediates for synthesising nucleoside aryl phosphoramidates | |
| HRP20120066T1 (hr) | Kalijeva sol inhibitora hiv integraze | |
| GEP20156366B (en) | Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use | |
| TW200716596A (en) | Substituted amide derivatives and methods of use | |
| TW200736258A (en) | Pyrimidine derivatives for the treatment of abnormal cell growth | |
| WO2009123776A3 (en) | Antiviral drugs for treatment of arenavirus infection | |
| WO2007048070A3 (en) | Pyrrolo-pyridine derivatives for the treatment of cancer diseases | |
| UA101305C2 (ru) | Антибактериальные производные хинолина | |
| WO2010042392A3 (en) | Hiv integrase inhibitors | |
| WO2009042094A3 (en) | Hiv protease inhibitors | |
| MX2009008463A (es) | Formulaciones biodisponibles de compuestos heterociclicos. | |
| MX2009007040A (es) | Derivados de mononitrato de isosorbida para el tratamiento de hipertension ocular. | |
| JO2725B1 (en) | Quinoline antibacterial derivatives | |
| MY157492A (en) | Pharmaceutical composition 271 | |
| JO2970B1 (en) | Quinoline antibacterial derivatives | |
| JO2685B1 (en) | Quinoline antibacterial derivatives | |
| WO2008059513A3 (en) | Compounds suitable as modulators of hdl | |
| UA101307C2 (ru) | Антибактериальные производные хинолина | |
| TW200833708A (en) | Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture |